Suchergebnis | Hamburg Open Science

Facetten

49 Einträge gefunden

SHIP1 Is Present but Strongly Downregulated in T-ALL, and after Restoration Suppresses Leukemia Growth in a T-ALL Xenotransplantation Mouse Model
2023 - Forschungsinformationssystem des UKE - frei zugänglich
Src family kinase targeting in head and neck tumor cells using SU6656, PP2 and dasatinib
2023 - Forschungsinformationssystem des UKE - frei zugänglich
Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1
2023 - Forschungsinformationssystem des UKE - frei zugänglich
A Lack of Effectiveness in the ATM-Orchestrated DNA Damage Response Contributes to the DNA Repair Defect of HPV-Positive Head and Neck Cancer Cells
2022 - Forschungsinformationssystem des UKE - frei zugänglich
Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy
2022 - Forschungsinformationssystem des UKE - frei zugänglich
Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model
2022 - Forschungsinformationssystem des UKE - frei zugänglich
Cytotoxic N-Methylpretrichodermamide B Reveals Anticancer Activity and Inhibits P-Glycoprotein in Drug-Resistant Prostate Cancer Cells
2022 - Forschungsinformationssystem des UKE - frei zugänglich
Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF Axis
2021 - Forschungsinformationssystem des UKE - frei zugänglich
Dual Inhibition of PARP and the Intra-S/G2 Cell Cycle Checkpoints Results in Highly Effective Radiosensitization of HPV-Positive HNSCC Cells
2021 - Forschungsinformationssystem des UKE - frei zugänglich
Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer
2020 - Forschungsinformationssystem des UKE
Improving the Efficacy of Tumor Radiosensitization Through Combined Molecular Targeting
2020 - Forschungsinformationssystem des UKE
Photoswitchable Azo- and Diazocine-Functionalized Derivatives of the VEGFR-2 Inhibitor Axitinib
2020 - Forschungsinformationssystem des UKE
Marine alkaloid monanchoxymycalin C: a new specific activator of JNK1/2 kinase with anticancer properties
2020 - Forschungsinformationssystem des UKE
Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death
2020 - Forschungsinformationssystem des UKE
Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer Cells
2020 - Forschungsinformationssystem des UKE
Cancer Cells Expressing Oncogenic Rat Sarcoma Show Drug-Addiction Toward Epidermal Growth Factor Receptor Antibodies Mediated by Sustained MAPK Signaling
2019 - Forschungsinformationssystem des UKE - frei zugänglich
Light-controlled inhibition of BRAFV600E kinase
2019 - Forschungsinformationssystem des UKE
The failure of cetuximab-based de-intensified regimes for HPV-positive OPSCC: A radiobiologists perspective
1. Rieckmann, Thorsten
2. Kriegs, Malte
2019 - Forschungsinformationssystem des UKE - frei zugänglich
Analyzing expression and phosphorylation of the EGF receptor in HNSCC
2019 - Forschungsinformationssystem des UKE - frei zugänglich
Axitinib: A Photoswitchable Approved Tyrosine Kinase Inhibitor
2018 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

SHIP1 Is Present but Strongly Downregulated in T-ALL, and after Restoration Suppresses Leukemia Growth in a T-ALL Xenotransplantation Mouse Model

Src family kinase targeting in head and neck tumor cells using SU6656, PP2 and dasatinib

Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1

A Lack of Effectiveness in the ATM-Orchestrated DNA Damage Response Contributes to the DNA Repair Defect of HPV-Positive Head and Neck Cancer Cells

Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy

Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model

Cytotoxic N-Methylpretrichodermamide B Reveals Anticancer Activity and Inhibits P-Glycoprotein in Drug-Resistant Prostate Cancer Cells

Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF Axis

Dual Inhibition of PARP and the Intra-S/G2 Cell Cycle Checkpoints Results in Highly Effective Radiosensitization of HPV-Positive HNSCC Cells

Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer

Improving the Efficacy of Tumor Radiosensitization Through Combined Molecular Targeting

Photoswitchable Azo- and Diazocine-Functionalized Derivatives of the VEGFR-2 Inhibitor Axitinib

Marine alkaloid monanchoxymycalin C: a new specific activator of JNK1/2 kinase with anticancer properties

Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death

Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer Cells

Cancer Cells Expressing Oncogenic Rat Sarcoma Show Drug-Addiction Toward Epidermal Growth Factor Receptor Antibodies Mediated by Sustained MAPK Signaling

Light-controlled inhibition of BRAFV600E kinase

The failure of cetuximab-based de-intensified regimes for HPV-positive OPSCC: A radiobiologists perspective

Analyzing expression and phosphorylation of the EGF receptor in HNSCC

Axitinib: A Photoswitchable Approved Tyrosine Kinase Inhibitor